Search Results

Filter
  • 1-10 of  5,083 results for ""CLINICAL trials""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

The Case for Human Challenge Trials in COVID-19.

  • Authors : Drewett GP; Melbourne Law School, University of Melbourne, Parkville, VIC, Australia. .; The Northern Hospital, Epping, VIC, Australia. .

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; SARS-CoV-2* ; Clinical Trials as Topic*/Clinical Trials as Topic*/Clinical Trials as Topic*/ethics

  • Source: Journal of bioethical inquiry [J Bioeth Inq] 2024 Mar; Vol. 21 (1), pp. 151-165. Date of Electronic Publication: 2023 Sep 18.Publisher: Springer Country of Publication: Netherlands NLM ID: 101250741 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Diversity of Participation in Clinical Trials and Influencing Factors: Findings from the Health Information National Trends Survey 2020.

  • Authors : Walker DM; Department of Family and Community Medicine, College of Medicine, The Ohio State University, 700 Ackerman Ave, Suite 4000, Columbus, OH, 43202, USA. .; The Center for the Advancement of Team Science, Analytics, and Systems Thinking (CATALYST), College of Medicine, The Ohio State University, Columbus, OH, USA. .

Subjects: Ethnicity* ; Minority Groups* ; Patient Participation*

  • Source: Journal of general internal medicine [J Gen Intern Med] 2023 Mar; Vol. 38 (4), pp. 961-969. Date of Electronic Publication: 2022 Sep 22.Publisher: Springer Country of Publication: United States NLM ID: 8605834 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Second-line tislelizumab versus chemotherapy in Japanese patients with advanced or metastatic esophageal squamous cell carcinoma: subgroup analysis from RATIONALE-302.

  • Authors : Hara H; Department of Gastroenterology, Saitama Cancer Center, Saitama, Japan.; Satoh T

Subjects: Antibodies, Monoclonal, Humanized* ; Esophageal Neoplasms*/Esophageal Neoplasms*/Esophageal Neoplasms*/pathology ; Esophageal Squamous Cell Carcinoma*/Esophageal Squamous Cell Carcinoma*/Esophageal Squamous Cell Carcinoma*/drug therapy

  • Source: Esophagus : official journal of the Japan Esophageal Society [Esophagus] 2024 Apr; Vol. 21 (2), pp. 102-110. Date of Electronic Publication: 2024 Jan 19.Publisher: Springer Country of Publication: Japan NLM ID: 101206627 Publication Model: Print-Electronic Cited Medium:

Record details

×
Editorial & Opinion

Letter to the Editor of Annals of Surgical Oncology Concerning "Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the USA".

  • Authors : Chiu CC; Department of General Surgery, E-Da Cancer Hospital, I-Shou University, Kaohsiung, Taiwan. .; Department of Medical Education and Research, E-Da Cancer Hospital, I-Shou University, Kaohsiung, Taiwan. .

Subjects: Appendiceal Neoplasms*/Appendiceal Neoplasms*/Appendiceal Neoplasms*/drug therapy ; Appendiceal Neoplasms*/Appendiceal Neoplasms*/Appendiceal Neoplasms*/surgery ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/drug therapy

  • Source: Annals of surgical oncology [Ann Surg Oncol] 2024 Apr; Vol. 31 (4), pp. 2405-2407. Date of Electronic Publication: 2023 Nov 16.Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

ASO Author Reflections: Nationwide Experience on Locally Advanced Pancreatic Cancer Surgery After Induction Chemotherapy in the Netherlands: A Stepping Stone for the PREOPANC-4 Trial.

Subjects: Induction Chemotherapy* ; Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/drug therapy ; Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/surgery

  • Source: Annals of surgical oncology [Ann Surg Oncol] 2024 Apr; Vol. 31 (4), pp. 2658-2659. Date of Electronic Publication: 2023 Dec 13.Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

A revisit of drugs and potential therapeutic targets against non-alcoholic fatty liver disease: learning from clinical trials.

  • Authors : Zhu S; Wuxi School of Medicine, Jiangnan University, Wuxi, China.; Wu Z

Subjects: Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/diagnosis; Humans ; Treatment Outcome

  • Source: Journal of endocrinological investigation [J Endocrinol Invest] 2024 Apr; Vol. 47 (4), pp. 761-776. Date of Electronic Publication: 2023 Oct 15.Publisher: Springer Country of Publication: Italy NLM ID: 7806594 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Adjuvant Trastuzumab Emtansine Versus Paclitaxel and Trastuzumab in Stage I HER2-Positive Breast Cancer: The ATEMPT Trial.

  • Authors : Khattak MN; Division of Breast Services, Cleveland Clinic Foundation, Cleveland, OH, USA.; Chichura AM

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy; Female ; Humans

  • Source: Annals of surgical oncology [Ann Surg Oncol] 2024 Mar; Vol. 31 (3), pp. 1423-1427. Date of Electronic Publication: 2023 Dec 21.Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

[First experiences with the implementation of EU Regulation 536/2014 (CTR) from the perspective of non-commercial academic research].

  • Authors : Fuhrmann C; Studienzentrale SZB, Institut für Klinische Chemie und Klinische Pharmakologie, Rheinische Friedrich-Wilhelms-Universität Bonn, Venusberg-Campus 1, 53127, Bonn, Deutschland. .; Reineke C

Subjects: Clinical Trials as Topic*/Clinical Trials as Topic*/Clinical Trials as Topic*/legislation & jurisprudence; Humans ; European Union

  • Source: Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz [Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz] 2023 Jan; Vol. 66 (1), pp. 38-44. Date of Electronic Publisher: Springer Country of Publication: Germany NLM ID: 101181368 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

[Main characteristics of the new authorisation procedure for clinical trials with medicinal products according to regulation (EU) no 536/2014 and the cooperation between the member states].

  • Authors : Sudhop T; Abteilung Informationstechnik/Klinische Prüfung, Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM), Kurt-Georg-Kiesinger-Allee 3, 53175, Bonn, Deutschland. .; Riedel C

Subjects: Clinical Trials as Topic*/Clinical Trials as Topic*/Clinical Trials as Topic*/legislation & jurisprudence ; Pharmaceutical Preparations*; Humans

  • Source: Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz [Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz] 2023 Jan; Vol. 66 (1), pp. 3-11. Date of Electronic Publisher: Springer Country of Publication: Germany NLM ID: 101181368 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

[The new approval procedure for clinical trials of medicinal products in the European Union-challenges for the pharmaceutical industry in Germany].

Subjects: Drug Industry* ; Clinical Trials as Topic*; Ethics Committees

  • Source: Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz [Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz] 2023 Jan; Vol. 66 (1), pp. 28-37. Date of Electronic Publisher: Springer Country of Publication: Germany NLM ID: 101181368 Publication Model: Print-Electronic Cited Medium:

Record details

×
  • 1-10 of  5,083 results for ""CLINICAL trials""